repair. TGF-␤1 may also play a key role in vascular remodeling process and myocardial hypertrophy through hypertension. Data exist that TGF-␤1 and angiotensin regulate the expression of each other and TGF-␤1 increases renin release from juxtaglomerular cells in the kidney. It has recently been shown that peripheral blood mononuclear cells from patients with essential hypertension produce more TGF-␤1 than normotensive controls and a correlation of blood pressure and circulating levels of TGF-␤1 was found in patients with hypertension due to end stage renal disease. We therefore evaluated if TGF-␤1 levels are also elevated in patients with essential hypertension.
Several studies indicate that insulin-resistance frequently correlates with hypertension. In order to identify a common pathophysiological pathway between the metabolic disorders and the vascular dysfunction, we investigated the interactions between Ang II and insulin on extracellular signal-regulated kinases (ERK1/2) activation in skin fibroblasts from normotensive subjects (NT), from insulin-sensitive (IS) and insulinresistant (IR) patients with essential hypertension (HT).
Skin fibroblasts from NT (nϭ5), IS-HT (nϭ4) and IR-HT (nϭ3) were cultured and used after four passages. ERK 1/2 expression and phosphorylation were measured by Western Blot using specific antibodies, respectively anti-ERK 1/2 and anti-pERK 1/2. ERK 1/2 were similarly expressed in skin fibroblasts in all the groups. Ang II (250 nM) induced a maximal increase in ERKs phosphorylation within 2 minutes (39%Ϯ6% for ERK1, 57% Ϯ10% for ERK2; pϽ0.01). The maximal effect on ERK 1/2 phosphorylation was obtained at 1M Ang II, EC 50 being approximately 10nM. The effect of Ang II on ERK1/2 phosphorylation was completely abolished by Losartan (1M), an Ang II-type 1 receptor inhibitor, but not by PD12339 (1M), an Ang II-type 2 receptor inhibitor. PD98059 (1M), a MEK-inhibitor, reduced the Ang II-induced ERK 1/2 phosphorylation by approximately 50%. ERK 1/2 phosporylation evoked by Ang II (250nM, 2 min) was significantly higher in fibroblasts from HT, than in fibroblasts from NT (ERK1: 41%Ϯ8% vs 33%Ϯ11%; ERK2:64%Ϯ13% vs 34%Ϯ10%, pϽ0.05). There was no difference on Ang II-induced ERK 1/2 activation in fibroblasts from IS-HT and IR-HT. Insulin concentration-dependently increased ERK1/2 phosphorylation. The effect of insulin (500pM, 10min) on ERK1/2 phosphorylation was not significantly different in NT and HT. Ang II (250nM, 2min) and Insulin (500pM,10min) had an addictive effect on ERK 1/2 phosphorylation only in NT, which was absent in IS-HT and IR-HT. Our results suggest that ERK 1/2 hyperresponsiveness in fibroblasts from HT, elicitable by Ang II, may have a role in the pathogenesis of essential hypertension. The similar behaviour of ERK 1/2 phosphorylation after Ang II and insulin in IS-HT and IR-HT proves that insulin-resistance associated to hypertension does not affect the ERK1/2 cascade. Rho kinase (ROCK) is a direct downstream effector of the monomeric GTPase rho and has recently been shown to a play an important role in neointimal formation in response to vessel injury, adding to the role in vessel contractility established earlier. This study, using human vascular smooth muscle cells (SMCs), examined the functional involvement of ROCK in the mitogenic and chemotactic processes which underlie vessel wound healing and remodelling.
Cultured saphenous vein SMCs were derived from patients undergoing bypass surgery using an explant method. Mitogenesis, chemotaxis, cell morphology and the distribution pattern of F-actin were determined using labelled thymidine incorporation, blind-well migration assays, phase contrast microscopy and fluorescence microscopy of cells stained with FITC-labelled phalloidin respectively.
Treatment of cells with the specific ROCK inhibitor Y27632 (1M-30M) dose-dependently inhibited DNA synthesis in response to platelet-derived growth factor-BB (PDGF-BB, 10 ng/ml) and foetal calf serum (FCS, 15% vol/vol) . DNA synthesis in response to PDGF-BB and FCS displayed a Y27632 insensitive component of 31Ϯ7% and 42Ϯ5% (meanϮstandard error of the mean, nϭ4 cell strains) of the untreated control values respectively. In contrast, peak stimulated chemotaxis in response to PDGF-BB (2 ng/ml) was completely abolished (nϭ4) at a concentration of 10M Y27632. When cells were plated sparsely (1000/ cm 2 ) to allow full spreading, subsequent addition of Y27632 (10M and 30M) resulted in time-dependent alterations in cell morphology. The most prominent feature was the development of neuron-like protrusions, appearing over a timescale of 1-4 hours after addition of ROCK inhibitor. These protusions were found to contain elongated actin filaments, indicating that ROCK inhibition could inititiate actin polymerisation.
It is concluded that ROCK has multiple functional roles in human SMCs. DNA synthesis proceeds via ROCK dependent and independent pathways whereas chemotaxis is critically dependent on ROCK activity. Active ROCK plays an important role in the maintenance of normal cell morphology, at least in part by regulation of actin polymerisation and organisation. Inhibition of ROCK activity, leading to altered regulation of the actin cytoskeleton and loss of control of morphology could explain the Y27632 induced abolition of chemotaxis, which requires a coordinated series of morphological rearrangements to effect mobility. Highly localised endogenous regulation of ROCK activity most likely plays an important part in the regulation of SMC chemotaxis. AJH-April 2001-VOL. 14, NO. 4 , PART 2 POSTERS: Cell Biology/Growth Factors Downloaded from https://academic.oup.com/ajh/article-abstract/14/S1/170A/135348 by guest on 06 April 2019
